{
  "folder": "IC-074",
  "content": "{{knowledge objective\n|Identifiant=OIC-074-14-A\n|Item_parent=Prescription and monitoring of psychotropic drugs (see item 330)\n|Item_parent_short=Prescription and monitoring of psychotropic drugs (see item 330)\n|Rank=A\n|Title=Anxiolytics: knowing the rules for correct use at all stages of life, particularly in elderly patients\n|Description=None\n|Rubric=Management\n|Contributors=\n|Order=14}}\nThe '''prescription of hypnotics''' and '''anxiolytics''' must be based on a '''careful analysis''' of the clinical situation, seeking to separate what falls under '''transient difficulties''' and '''reactions to a non-psychiatric pathology''', and '''confirmed psychiatric pathology'''. It must be '''<u>regularly</u> reassessed'''. It '''should not be stopped <u>brutally</u>''' after a course of treatment several weeks old.\n\n'''As part of this prescription:'''\n\n* There is no need to combine two anxiolytics (benzodiazepines or others) in the treatment of anxiety;\n* There is no need to combine two hypnotics;\n* There is no need to combine two benzodiazepines.\n* There is no need to prescribe benzodiazepines without taking into account the regulatory maximum prescription periods (including the withdrawal period and with regular reassessment):\n** 12 weeks for anxiolytics;\n** 4 weeks for hypnotics;\n\n* An anxiolytic or hypnotic prescription should not be initiated without complying with the official recommended doses, and without starting with the lowest dose;\n* An anxiolytic or hypnotic prescription should not be systematically renewed without reassessment.\n\n\n'''Concerning benzodiazepines:'''\n\n* At the time of initiation of treatment: ''''<u>initiation</u>'':\n** Treatment will be prescribed at the minimum effective dose;\n** The treatment and its transient nature are explained to the patient;\n** Lower doses will be used in elderly patients;\n* At the time of '''<u>maintenance treatment</u>''':\n** It will be stopped as soon as possible;\n* At the time of ''''''<u>stopping treatment</u>'' (particularly in elderly subjects):\n** Assess the patient's motivations, their attachment to the treatment ;\n** Discontinuation should always be gradual, over a period of several weeks to several months;\n** Specialised management should be sought for :\n*** A) Associated severe psychiatric disorders;\n*** B) Dependence on other drugs;\n*** C) Combination with other psychotropic drugs;\n*** D) intractable insomnia;\n** The aim is to stop taking benzodiazepines.\n** There is no argument for proposing drug replacement therapy when discontinuing benzodiazepines in elderly patients;\n** Non-medicinal support measures should be put in place for as long as necessary.",
  "question": {
    "question": "What is the recommended approach for stopping benzodiazepine treatment in elderly patients?",
    "option_a": "Stopping benzodiazepine treatment abruptly after a course of several weeks is acceptable.",
    "option_b": "Gradual discontinuation of benzodiazepine treatment over a period of several weeks to several months is recommended.",
    "option_c": "Drug replacement therapy is a suitable option for discontinuing benzodiazepine treatment in elderly patients.",
    "option_d": "Non-medicinal support measures are not necessary when stopping benzodiazepine treatment in elderly patients.",
    "correct_option": "B"
  }
}